Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain
Open Access
- 1 August 2018
- journal article
- review article
- Published by Elsevier in Neurobiology of Pain
- Vol. 4, 27-34
Abstract
No abstract availableKeywords
This publication has 154 references indexed in Scilit:
- Spinal Cord NMDA Receptor-Mediated Activation of Mammalian Target of Rapamycin Is Required for the Development and Maintenance of Bone Cancer-Induced Pain Hypersensitivities in RatsThe Journal of Pain, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA–induced dyskinesiaNature Neuroscience, 2011
- Naturally Secreted Amyloid-β Increases Mammalian Target of Rapamycin (mTOR) Activity via a PRAS40-mediated MechanismJournal of Biological Chemistry, 2011
- Dopaminergic pathway reconstruction by Akt/Rheb‐induced axon regenerationAnnals of Neurology, 2011
- Mammalian Target of Rapamycin Signaling in the Spinal Cord Is Required for Neuronal Plasticity and Behavioral Hypersensitivity Associated With Neuropathy in the RatThe Journal of Pain, 2010
- Expression and distribution of mTOR, p70S6K, 4E-BP1, and their phosphorylated counterparts in rat dorsal root ganglion and spinal cord dorsal hornBrain Research, 2010
- Hydrogen peroxide inhibits mTOR signaling by activation of AMPKα leading to apoptosis of neuronal cellsLaboratory Investigation, 2010
- Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and TauJournal of Biological Chemistry, 2010
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009